Appili Therapeutics Inc (APLIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 83 | 75 | 0 | -9 | 77 |
| Gross Profit | 83 | 75 | N/A | -9 | 77 |
| Operating Expenses | 597 | 1,018 | 1,159 | 1,750 | 1,551 |
| Operating Income | -515 | -943 | -1,159 | -1,758 | -1,473 |
| Interest Expense | 271 | -159 | 351 | 855 | 373 |
| Other Income | 112 | 92 | 630 | 2,824 | 1,465 |
| Pre-tax Income | -674 | -693 | -881 | 211 | -382 |
| Income Tax | 7 | 25 | 22 | 6 | 7 |
| Net Income Continuous | -681 | -718 | -903 | 205 | -389 |
| Net Income | $-681 | $-718 | $-903 | $191 | $-375 |
| EPS Basic Total Ops | -0.01 | -0.01 | -0.01 | -0.01 | 0.00 |
| EPS Basic Continuous Ops | -0.01 | -0.01 | -0.01 | 0.00 | 0.00 |
| EPS Diluted Total Ops | -0.01 | -0.01 | -0.01 | -0.01 | 0.00 |
| EPS Diluted Continuous Ops | -0.01 | -0.01 | -0.01 | 0.00 | 0.00 |
| EPS Diluted Before Non-Recurring Items | -0.01 | -0.01 | -0.01 | 0.00 | 0.00 |
| EBITDA(a) | $-515 | $-940 | $-1,157 | $-1,756 | $-1,471 |